The DLBCL patients in the PHL group had a younger age; higher levels of ALT, total bilirubin, GGT, serum albumin and platelet count; and lower levels of hemoglobin, AST, ALP and LDH. This evidence concerns the gene ALB and diffuse large B-cell lymphoma.